Equity Profile

BCPC

Balchem Corporation

MaterialsSpecialty Chemicals$5.2B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Balchem Corporation operates in the specialty chemicals sector, focusing on providing innovative solutions for various industries, including food, pharmaceuticals, and agriculture. With a market cap of $5 billion, the company plays a significant role in the materials sector, particularly in the production of specialty chemicals that enhance product performance and safety.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and drive sales, crucial for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

BCPC Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+3.47%

Avg Stock Reaction

+0.12%

Last Quarter Recap

In Q1 2026, Balchem reported an EPS of $1.33, matching analyst expectations but showing no revenue figures. The stock reacted negatively, dropping 6.76% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for Balchem's upcoming earnings are mixed, given the lack of analyst estimates and recent performance. Investors are keen to see if the company can maintain its profitability amid market challenges.

Bull Case

Optimistically, if Balchem can report strong EPS growth and improved revenue figures, it may signal robust demand for its products and a positive outlook for the future.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of declining margins, it could raise concerns about its competitive position and long-term viability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS figure for Q2-2026?

The EPS number will be critical in assessing the company's profitability and whether it can maintain its earnings momentum.

How is Balchem managing its costs and margins in the current economic environment?

Understanding cost management and margin trends will be essential for evaluating the company's operational efficiency and long-term sustainability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Balchem's ability to maintain margins despite rising costs, as historical performance shows resilience in challenging environments.

Supporting Evidence

Balchem has a strong track record of beating EPS estimates, with a 75% beat rate over the last eight quarters.

The options market is pricing in a larger move than historical averages, suggesting heightened expectations that may not be justified.

Recent trends in specialty chemicals indicate a potential uptick in demand that could benefit Balchem.

Key Risk

If EPS comes in above $1.40, it could challenge the current bearish sentiment and shift market perceptions.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Balchem can sustain its earnings growth amid rising costs and competitive pressures.

Bull Confirmed If

An EPS of $1.40 or higher would confirm strong earnings growth and investor confidence.

Bear Confirmed If

An EPS below $1.25 would raise concerns about profitability and market competitiveness.

Pre-Earnings Positioning

Options Market

Implied Move

±10.08%

Historical Avg

±3.0%

Pricing rich

The options market is pricing in a significant move of over 10%, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±10.1% while BCPC has averaged ±3.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

25.3%

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Materials

n=30

Fade rate: 14 of 30 (47%)

This setup has occurred 30 times across Materials in the last 2 years. 14 of 30 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 4.8%, with a raw directional average of +0.6% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Balchem beats expectations, history suggests the stock could rise around 2.98% on the first day, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

Should the company miss expectations, history indicates a potential drop of about 0.73%, raising concerns about future performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on margins.
2Details on revenue growth in key segments, particularly food and pharmaceuticals.
3Management's outlook on market conditions and demand for specialty chemicals.
4Insights into any new product developments or innovations.
5Comments on competitive pressures and how the company plans to address them.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

DYNBMO

Dyne Therapeutics, Inc.

PreviewView

Jul27

ARLPBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and drive sales, crucial for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

BCPC Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+3.47%

Avg Stock Reaction

+0.12%

Last Quarter Recap

In Q1 2026, Balchem reported an EPS of $1.33, matching analyst expectations but showing no revenue figures. The stock reacted negatively, dropping 6.76% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

Optimistically, if Balchem can report strong EPS growth and improved revenue figures, it may signal robust demand for its products and a positive outlook for the future.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of declining margins, it could raise concerns about its competitive position and long-term viability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS figure for Q2-2026?

The EPS number will be critical in assessing the company's profitability and whether it can maintain its earnings momentum.

How is Balchem managing its costs and margins in the current economic environment?

Understanding cost management and margin trends will be essential for evaluating the company's operational efficiency and long-term sustainability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Balchem's ability to maintain margins despite rising costs, as historical performance shows resilience in challenging environments.

Supporting Evidence

Balchem has a strong track record of beating EPS estimates, with a 75% beat rate over the last eight quarters.

The options market is pricing in a larger move than historical averages, suggesting heightened expectations that may not be justified.

Recent trends in specialty chemicals indicate a potential uptick in demand that could benefit Balchem.

Key Risk

If EPS comes in above $1.40, it could challenge the current bearish sentiment and shift market perceptions.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Balchem can sustain its earnings growth amid rising costs and competitive pressures.

Bull Confirmed If

An EPS of $1.40 or higher would confirm strong earnings growth and investor confidence.

Bear Confirmed If

An EPS below $1.25 would raise concerns about profitability and market competitiveness.

Pre-Earnings Positioning

Options Market

Implied Move

±10.08%

Historical Avg

±3.0%

Pricing rich

The options market is pricing in a significant move of over 10%, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±10.1% while BCPC has averaged ±3.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

25.3%

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Materials

n=30

Fade rate: 14 of 30 (47%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Balchem beats expectations, history suggests the stock could rise around 2.98% on the first day, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

Should the company miss expectations, history indicates a potential drop of about 0.73%, raising concerns about future performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on margins.
2Details on revenue growth in key segments, particularly food and pharmaceuticals.
3Management's outlook on market conditions and demand for specialty chemicals.
4Insights into any new product developments or innovations.
5Comments on competitive pressures and how the company plans to address them.